Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Increase (Decrease) in Other Current Assets

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Increase (Decrease) in Other Current Assets

VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Other Current Assets of -$30.63 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-12

  • VYOME HOLDINGS, INC. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $2.75K.
  • VYOME HOLDINGS, INC. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$33.39K.
  • VYOME HOLDINGS, INC. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$13.90K.
  • VYOME HOLDINGS, INC. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$30.45K.
  • VYOME HOLDINGS, INC. increase (decrease) in other current assets for fiscal 2025 was -$75.98K.
  • VYOME HOLDINGS, INC. increase (decrease) in other current assets for fiscal 2024 was -$78.74K.
  • VYOME HOLDINGS, INC. increase (decrease) in other current assets for fiscal 2020 was $1.80M.
  • VYOME HOLDINGS, INC. increase (decrease) in other current assets for fiscal 2019 was -$411.00K.
Period endIncrease (Decrease) in Other Current Assets 3 monthIncrease (Decrease) in Other Current Assets 6 monthIncrease (Decrease) in Other Current Assets 6 month as first filedIncrease (Decrease) in Other Current Assets 9 monthIncrease (Decrease) in Other Current Assets 12 month
2026-06-30$2.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$30.63K
10-Q · filed 2026-08-12
-$44.53K
derived: sum of 3 quarters · filed 2026-08-12
-$74.98K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$33.39K
10-Q · filed 2026-05-12
-$47.29K
derived: sum of 2 quarters · filed 2026-05-12
-$77.74K
derived: sum of 3 quarters · filed 2026-05-12
-$84.11K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$13.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
-$44.35K
derived: sum of 2 quarters · filed 2026-03-18
-$50.73K
derived: sum of 3 quarters · filed 2026-08-12
-$75.98K
10-K · filed 2026-03-18
2025-09-30-$30.45K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$36.83K
derived: sum of 2 quarters · filed 2026-08-12
-$62.08K
10-Q · filed 2025-11-14
-$120.25K
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$6.38K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$31.63K
10-Q · filed 2026-08-12
-$31.64K
8-K · filed 2025-09-02
-$89.80K
derived: sum of 3 quarters · filed 2026-08-12
-$101.16K
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$25.25K
10-Q · filed 2026-05-12
-$83.42K
derived: sum of 2 quarters · filed 2026-05-12
-$94.78K
derived: sum of 3 quarters · filed 2026-05-12
2024-12-31-$58.17K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
-$69.53K
derived: sum of 2 quarters · filed 2026-03-18
-$78.74K
10-K · filed 2026-03-18
2024-09-30-$11.36K
derived: 10-Q 9 month − 8-K 6 month · filed 2025-11-14
-$20.58K
10-Q · filed 2025-11-14
2024-06-30-$9.21K
8-K · filed 2025-09-02
2021-03-31-$108.00K
10-Q · filed 2021-05-12
$307.00K
derived: sum of 2 quarters · filed 2021-05-12
-$149.00K
derived: sum of 3 quarters · filed 2021-05-12
-$1.13M
derived: sum of 4 quarters · filed 2021-05-12
2020-12-31$415.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$41.00K
derived: sum of 2 quarters · filed 2021-03-12
-$1.02M
derived: sum of 3 quarters · filed 2021-03-12
$1.80M
10-K · filed 2021-03-12
2020-09-30-$456.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$1.44M
derived: sum of 2 quarters · filed 2020-11-06
$1.39M
10-Q · filed 2020-11-06
$2.58M
derived: sum of 4 quarters · filed 2021-05-12
2020-06-30-$983.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$1.84M
10-Q · filed 2020-07-30
$3.04M
derived: sum of 3 quarters · filed 2021-05-12
$3.19M
derived: sum of 4 quarters · filed 2021-05-12
2020-03-31$2.83M
10-Q · filed 2021-05-12
$4.02M
derived: sum of 2 quarters · filed 2021-05-12
$4.18M
derived: sum of 3 quarters · filed 2021-05-12
$3.34M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$1.35M
derived: sum of 2 quarters · filed 2021-03-12
$512.00K
derived: sum of 3 quarters · filed 2021-03-12
-$411.00K
10-K · filed 2021-03-12
2019-09-30$156.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$681.00K
derived: sum of 2 quarters · filed 2020-11-06
-$1.60M
10-Q · filed 2020-11-06
-$897.00K
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30-$837.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
-$1.76M
10-Q · filed 2020-07-30
-$1.05M
derived: sum of 3 quarters · filed 2020-07-30
-$1.00M
derived: sum of 4 quarters · filed 2020-07-30
2019-03-31-$923.00K
10-Q · filed 2020-06-19
-$216.00K
derived: sum of 2 quarters · filed 2020-06-19
-$164.00K
derived: sum of 3 quarters · filed 2020-06-19
-$494.00K
derived: sum of 4 quarters · filed 2020-06-19
2018-12-31$707.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$759.00K
derived: sum of 2 quarters · filed 2020-02-27
$429.00K
derived: sum of 3 quarters · filed 2020-02-27
-$98.00K
10-K · filed 2020-02-27
2018-09-30$52.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$278.00K
derived: sum of 2 quarters · filed 2019-11-08
-$805.00K
10-Q · filed 2019-11-08
-$95.00K
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$330.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
-$857.00K
10-Q · filed 2019-07-24
-$147.00K
derived: sum of 3 quarters · filed 2019-07-24
$152.00K
derived: sum of 4 quarters · filed 2019-07-24
2018-03-31-$527.00K
10-Q · filed 2019-05-10
$183.00K
derived: sum of 2 quarters · filed 2019-05-10
$482.00K
derived: sum of 3 quarters · filed 2019-05-10
$183.00K
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$710.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$1.01M
derived: sum of 2 quarters · filed 2019-02-22
$710.00K
derived: sum of 3 quarters · filed 2019-02-22
$470.00K
10-K · filed 2019-02-22
2017-09-30$299.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$0.00
derived: sum of 2 quarters · filed 2018-11-02
-$240.00K
10-Q · filed 2018-11-02
-$1.85M
derived: sum of 4 quarters · filed 2018-11-02
2017-06-30-$299.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$539.00K
10-Q · filed 2018-08-02
-$2.15M
derived: sum of 3 quarters · filed 2018-08-02
$492.00K
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31-$240.00K
10-Q · filed 2018-05-10
-$1.85M
derived: sum of 2 quarters · filed 2018-05-10
$791.00K
derived: sum of 3 quarters · filed 2018-05-10
$731.00K
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31-$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$1.03M
derived: sum of 2 quarters · filed 2018-03-05
$971.00K
derived: sum of 3 quarters · filed 2018-03-05
$985.00K
10-K · filed 2018-03-05
2016-09-30$2.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$2.58M
derived: sum of 2 quarters · filed 2017-11-03
$2.60M
10-Q · filed 2017-11-03
$2.53M
derived: sum of 4 quarters · filed 2018-03-05
2016-06-30-$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$46.00K
10-Q · filed 2017-08-02
-$112.00K
derived: sum of 3 quarters · filed 2018-03-05
2016-03-31$14.00K
10-Q · filed 2017-05-10
-$52.00K
derived: sum of 2 quarters · filed 2018-03-05
2015-12-31-$66.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
-$27.00K
10-K · filed 2018-03-05
2015-09-30$39.00K
10-Q · filed 2016-11-10
2014-12-31$109.00K
10-K · filed 2017-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36